Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Risk Factors Collaborators

Abstract

Background: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of risk factor exposure and attributable burden of disease. By providing estimates over a long time series, this study can monitor risk exposure trends critical to health surveillance and inform policy debates on the importance of addressing risks in context.

Methods: We used the comparative risk assessment framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2016. This study included 481 risk-outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk (RR) and exposure estimates from 22 717 randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources, according to the GBD 2016 source counting methods. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. Finally, we explored four drivers of trends in attributable burden: population growth, population ageing, trends in risk exposure, and all other factors combined.

Findings: Since 1990, exposure increased significantly for 30 risks, did not change significantly for four risks, and decreased significantly for 31 risks. Among risks that are leading causes of burden of disease, child growth failure and household air pollution showed the most significant declines, while metabolic risks, such as body-mass index and high fasting plasma glucose, showed significant increases. In 2016, at Level 3 of the hierarchy, the three leading risk factors in terms of attributable DALYs at the global level for men were smoking (124·1 million DALYs [95% UI 111·2 million to 137·0 million]), high systolic blood pressure (122·2 million DALYs [110·3 million to 133·3 million], and low birthweight and short gestation (83·0 million DALYs [78·3 million to 87·7 million]), and for women, were high systolic blood pressure (89·9 million DALYs [80·9 million to 98·2 million]), high body-mass index (64·8 million DALYs [44·4 million to 87·6 million]), and high fasting plasma glucose (63·8 million DALYs [53·2 million to 76·3 million]). In 2016 in 113 countries, the leading risk factor in terms of attributable DALYs was a metabolic risk factor. Smoking remained among the leading five risk factors for DALYs for 109 countries, while low birthweight and short gestation was the leading risk factor for DALYs in 38 countries, particularly in sub-Saharan Africa and South Asia. In terms of important drivers of change in trends of burden attributable to risk factors, between 2006 and 2016 exposure to risks explains an 9·3% (6·9-11·6) decline in deaths and a 10·8% (8·3-13·1) decrease in DALYs at the global level, while population ageing accounts for 14·9% (12·7-17·5) of deaths and 6·2% (3·9-8·7) of DALYs, and population growth for 12·4% (10·1-14·9) of deaths and 12·4% (10·1-14·9) of DALYs. The largest contribution of trends in risk exposure to disease burden is seen between ages 1 year and 4 years, where a decline of 27·3% (24·9-29·7) of the change in DALYs between 2006 and 2016 can be attributed to declines in exposure to risks.

Interpretation: Increasingly detailed understanding of the trends in risk exposure and the RRs for each risk-outcome pair provide insights into both the magnitude of health loss attributable to risks and how modification of risk exposure has contributed to health trends. Metabolic risks warrant particular policy attention, due to their large contribution to global disease burden, increasing trends, and variable patterns across countries at the same level of development. GBD 2016 findings show that, while it has huge potential to improve health, risk modification has played a relatively small part in the past decade.

Funding: The Bill & Melinda Gates Foundation, Bloomberg Philanthropies.

Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Relationship between SEVs and SDI for the three metabolic, behavioural, and environmental or occupational risk factors that are responsible for the largest number of attributable DALYs globally Each point corresponds to a country in either 1990 (red) or 2016 (blue). Pearson correlation coefficients have been estimated to summarise the relationship between SEVs and SDI in 1990 and in 2016. SEVs=summary exposure values. SDI=Socio-demographic Index. DALYs=disability-adjusted life-years.
Figure 2
Figure 2
DALYs attributable to all Level 2 risk factors apportioned by Level 2 cause for each risk, both sexes combined, 2016, at the global level (A); for low SDI countries (B); for low-middle SDI countries (C); for middle SDI countries (D); for middle-high SDI countries (E); and for high SDI countries (F) DALYs from causes attributable to each risk factor are shown in different colours. Cutoffs on the SDI scale for the quintiles were selected based on examining the entire distribution of locations between 1980 and 2016. DALYs=disability-adjusted life-years. SDI=Socio-demographic Index.
Figure 3
Figure 3
Leading 30 Level 3 risk factors by attributable DALYs at the global level, 1990, 2006, and 2016, for males (A) and females (B) Risks are connected by lines between time periods. Behavioural risk factors are shown in red, environmental risks in blue, and metabolic risks in green. For the time period of 1990 to 2006 and for 2006–16, three measures of change are shown: percent change in the number of DALYs, percent change in the all-age DALY rate, and percent change in the age-standardised DALY rate. Statistically significant increases or decreases are shown in bold (p

Figure 4

Relationship between attributable DALYs in…

Figure 4

Relationship between attributable DALYs in 2016 for Level 3 risk factors and annualised…

Figure 4
Relationship between attributable DALYs in 2016 for Level 3 risk factors and annualised rate of change in SEV, at the global level, both sexes combined, 1990–2016 DALYs are represented on a logarithmic scale. Risks shown exhibited a statistically significant change in SEV between 1990 and 2016. The following six risks, each of which is responsible for fewer than 100 thousand DALYs, are not shown: occupational exposure to benzene, beryllium, cadmium, chromium, formaldehyde, and trichloroethylene. DALYs=disability-adjusted life-years. SEV=summary exposure value. Ambient PM=ambient particulate matter pollution. Alcohol=alcohol use. Arsenic=occupational exposure to arsenic. Asbestos=occupational exposure to asbestos. Asthmagens=occupational asthmagens. BMD=low bone mineral density. BMI=high body-mass index. Calcium=diet low in calcium. Cholesterol=high total cholesterol. Diesel=occupational exposure to diesel engine exhaust. Disc breast=discontinued breastfeeding. Drugs=drug use. Ergonomics=occupational ergonomic factors. Fibre=diet low in fibre. FPG=high fasting plasma glucose. Fruits=diet low in fruits. Handwashing=no access to handwashing facility. Household air=household air pollution from solid fuels. Impaired kidney=impaired kidney function. IPV=intimate partner violence. Iron=iron deficiency. Lead=lead exposure. Legumes=diet low in legumes. Milk=diet low in milk. Nickel=occupational exposure to nickel. Noise=occupational noise. Nuts and seeds=diet low in nuts and seeds. Occupational SHS=occupational exposure to second-hand smoke. Omega 3=diet low in seafood omega 3 fatty acids. Ozone=ambient ozone pollution. PAH=occupational exposure to polycyclic aromatic hydrocarbons. Part breastfeeding=non-exclusive breastfeeding. Physical activity=low physical activity. PM, gases, and fumes=occupational particulate matter, gases, and fumes. Processed meat=diet high in processed meat. PUFA=diet low in polyunsaturated fatty acids. Radon=residential radon. Red meat=diet high in red meat. Sanitation=unsafe sanitation. SBP=high systolic blood pressure. Sexual abuse=childhood sexual abuse. SHS=second-hand smoke. Silica=occupational exposure to silica. Smokeless=smokeless tobacco. Sodium=diet high in sodium. Stunting=child stunting. Sugar-sweetened beverages=diet high in sugar-sweetened beverages. Sulfuric acid=occupational exposure to sulfuric acid. Transfatty acids=diet high in transfatty acids. Underweight=child underweight. Vegetables=diet low in vegetables. Vitamin A=vitamin A deficiency. Wasting=child wasting. Water=unsafe water source. Whole grains=diet low in whole grains. Zinc=zinc deficiency.

Figure 5

Percent change in deaths (A)…

Figure 5

Percent change in deaths (A) and DALYs (B) at the global level, 2006–16,…

Figure 5
Percent change in deaths (A) and DALYs (B) at the global level, 2006–16, due to population growth, population ageing, trends in exposure to all risks included in GBD 2016, and and all other (risk-deleted or residual) factors Results are shown for all causes combined; communicable, maternal, neonatal, and nutritional diseases; non-communicable diseases; and injuries. DALYs=disability-adjusted life-years.

Figure 6

Percent change in all-cause DALYs,…

Figure 6

Percent change in all-cause DALYs, by age, at the global level, 2006-2016, due…

Figure 6
Percent change in all-cause DALYs, by age, at the global level, 2006-2016, due to the following drivers: population growth, population ageing, trends in exposure to all risks included in GBD 2016, and all other factors DALYs=disability-adjusted life-years.
Figure 4
Figure 4
Relationship between attributable DALYs in 2016 for Level 3 risk factors and annualised rate of change in SEV, at the global level, both sexes combined, 1990–2016 DALYs are represented on a logarithmic scale. Risks shown exhibited a statistically significant change in SEV between 1990 and 2016. The following six risks, each of which is responsible for fewer than 100 thousand DALYs, are not shown: occupational exposure to benzene, beryllium, cadmium, chromium, formaldehyde, and trichloroethylene. DALYs=disability-adjusted life-years. SEV=summary exposure value. Ambient PM=ambient particulate matter pollution. Alcohol=alcohol use. Arsenic=occupational exposure to arsenic. Asbestos=occupational exposure to asbestos. Asthmagens=occupational asthmagens. BMD=low bone mineral density. BMI=high body-mass index. Calcium=diet low in calcium. Cholesterol=high total cholesterol. Diesel=occupational exposure to diesel engine exhaust. Disc breast=discontinued breastfeeding. Drugs=drug use. Ergonomics=occupational ergonomic factors. Fibre=diet low in fibre. FPG=high fasting plasma glucose. Fruits=diet low in fruits. Handwashing=no access to handwashing facility. Household air=household air pollution from solid fuels. Impaired kidney=impaired kidney function. IPV=intimate partner violence. Iron=iron deficiency. Lead=lead exposure. Legumes=diet low in legumes. Milk=diet low in milk. Nickel=occupational exposure to nickel. Noise=occupational noise. Nuts and seeds=diet low in nuts and seeds. Occupational SHS=occupational exposure to second-hand smoke. Omega 3=diet low in seafood omega 3 fatty acids. Ozone=ambient ozone pollution. PAH=occupational exposure to polycyclic aromatic hydrocarbons. Part breastfeeding=non-exclusive breastfeeding. Physical activity=low physical activity. PM, gases, and fumes=occupational particulate matter, gases, and fumes. Processed meat=diet high in processed meat. PUFA=diet low in polyunsaturated fatty acids. Radon=residential radon. Red meat=diet high in red meat. Sanitation=unsafe sanitation. SBP=high systolic blood pressure. Sexual abuse=childhood sexual abuse. SHS=second-hand smoke. Silica=occupational exposure to silica. Smokeless=smokeless tobacco. Sodium=diet high in sodium. Stunting=child stunting. Sugar-sweetened beverages=diet high in sugar-sweetened beverages. Sulfuric acid=occupational exposure to sulfuric acid. Transfatty acids=diet high in transfatty acids. Underweight=child underweight. Vegetables=diet low in vegetables. Vitamin A=vitamin A deficiency. Wasting=child wasting. Water=unsafe water source. Whole grains=diet low in whole grains. Zinc=zinc deficiency.
Figure 5
Figure 5
Percent change in deaths (A) and DALYs (B) at the global level, 2006–16, due to population growth, population ageing, trends in exposure to all risks included in GBD 2016, and and all other (risk-deleted or residual) factors Results are shown for all causes combined; communicable, maternal, neonatal, and nutritional diseases; non-communicable diseases; and injuries. DALYs=disability-adjusted life-years.
Figure 6
Figure 6
Percent change in all-cause DALYs, by age, at the global level, 2006-2016, due to the following drivers: population growth, population ageing, trends in exposure to all risks included in GBD 2016, and all other factors DALYs=disability-adjusted life-years.

References

    1. Been JV, Sheikh A. Risk factors for neonatal disorders and the Global Burden of Disease. Lancet. 2016;388:560–561.
    1. Britton A, Bell S. The protective effects of moderate drinking: lies, damned lies, and… selection biases? Addict Abingdon Engl. 2017;112:218–219.
    1. Steenland K. Excess deaths due to occupation. Occup Env Med. 2016;73:497–498.
    1. Forouzanfar M, Afshin A, Alexander LT, Anderson H, Bhutta Z, Murray CJL. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–1724.
    1. Lim SS, Vos T, Flaxman AD. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260.
    1. Forouzanfar MH, Alexander L, Anderson HR. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–2323.
    1. Micha R, Khatibzadeh S, Shi P, Andrews KG, Engell RE, Mozaffarian D. Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys worldwide. BMJ Open. 2015;5:e008705.
    1. Singh GM, Micha R, Khatibzadeh S. Global, regional, and national consumption of sugar-sweetened beverages, fruit juices, and milk: a systematic assessment of beverage intake in 187 countries. PLoS One. 2015;10:e0124845.
    1. Singh GM, Micha R, Khatibzadeh S, Lim S, Ezzati M, Mozaffarian D. Estimated Global, Regional, and National Disease Burdens Related to Sugar-Sweetened Beverage Consumption in 2010. Circulation. 2015;132:639–666.
    1. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13:788–794.
    1. SPRINT Research Group. Wright JT, Williamson JD. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–2116.
    1. Yusuf S, Bosch J, Dagenais G. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016;374:2021–2031.
    1. Murray CJ, Lopez AD. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiol Camb Mass. 1999;10:594–605.
    1. Stevens GA, Alkema L, Black RE. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016;388:e19–e23.
    1. American Institute for Cancer Research . Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research; Washington, DC: 2007. (accessed Sept 2, 2017).
    1. Džeroski S, Ženko B. Is Combining Classifiers with Stacking Better than Selecting the Best One? Mach Learn. 2004;54:255–273.
    1. Massey FJ. The Kolmogorov-Smirnov Test for Goodness of Fit. J Am Stat Assoc. 1951;46:68–78.
    1. Flaxman AD, Vos T, Murray CJL, editors. An Integrative Metaregression Framework for Descriptive Epidemiology. 1st edn. University of Washington Press; Seattle: 2015.
    1. Gupta PD. Standardization and Decomposition of Rates: A User's Manual. US Department of Commerce, Economics and Statistics Administration, Bureau of the Census; 1993.
    1. Ford ES, Ajani UA, Croft JB. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000. N Engl J Med. 2007;356:2388–2398.
    1. Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101:1182–1189.
    1. Scarborough P, Wickramasinghe K, Bhatnagar P, Rayner M. Trends in coronary heart disease, 1961-2011. British Heart Foudation; London, England: 2011.
    1. Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet. 2010;376:1775–1784.
    1. Goetzel RZ, Anderson DR, Whitmer RW. The relationship between modifiable health risks and health. J Occup Environ Med. 1998;40:843–854.
    1. Attard SM, Herring AH, Zhang B, Du S, Popkin BM, Gordon-Larsen P. Associations between age, cohort, and urbanization with SBP and DBP in China: a population-based study across 18 years. J Hypertens. 2015;33:948–956.
    1. Song L, Shen L, Li H. Height and prevalence of hypertension in a middle-aged and older Chinese population. Sci Rep. 2016;6:39480.
    1. Muntner P, Gu D, Wu X. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension. 2004;43:578–585.
    1. Coleman K, Hamblin R. Can pay-for-performance improve quality and reduce health disparities? PLoS Med. 2007;4:e216.
    1. Smith PC, York N. Quality Incentives: The Case Of U.K. General Practitioners. Health Aff (Millwood) 2004;23:112–118.
    1. Morrissey Y, Bedford M, Irving J, Farmer CKT. Older people remain on blood pressure agents despite being hypotensive resulting in increased mortality and hospital admission. Age Ageing. 2016;45:783–788.
    1. WHO . WHO framework convention on tobacco control. World Health Organization; Geneva: 2003.
    1. NCD Risk Factor Collaboration Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387:1377–1396.
    1. Ng M, Fleming T, Robinson M. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–781.
    1. Swinburn BA, Sacks G, Hall KD. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804–814.
    1. Hawkes C, Smith TG, Jewell J. Smart food policies for obesity prevention. Lancet. 2015;385:2410–2421.
    1. Roberto CA, Swinburn B, Hawkes C. Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking. Lancet. 2015;385:2400–2409.
    1. WHO . Global nutrition policy review: What does it take to scale up nutrition action? World Health Organization; Geneva: 2013. (accessed May 29, 2017).
    1. Colchero MA, Popkin BM, Rivera JA, Ng SW. Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study. BMJ. 2016;352:h6704.
    1. Clark SE, Hawkes C, Murphy SME, Hansen-Kuhn KA, Wallinga D. Exporting obesity: US farm and trade policy and the transformation of the Mexican consumer food environment. Int J Occup Environ Health. 2012;18:53–65.
    1. Alvarado M, Kostova D, Suhrcke M. Trends in beverage prices following the introduction of a tax on sugar-sweetened beverages in Barbados. Prev Med. 2017 doi: 10.1016/j.ypmed.2017.07.013. published online July 15.
    1. Mazzocchi M. The impact of the French soda tax on prices, purchases and tastes: an ex post evaluation. Applied Economics. 2016;48:3976–3994.
    1. Briggs AD, Mytton OT, Madden D, O'Shea D, Rayner M, Scarborough P. The potential impact on obesity of a 10% tax on sugar-sweetened beverages in Ireland, an effect assessment modelling study. BMC Public Health. 2013;13:860.
    1. Cabrera Escobar MA, Veerman JL, Tollman SM, Bertram MY, Hofman KJ. Evidence that a tax on sugar sweetened beverages reduces the obesity rate: a meta-analysis. BMC Public Health. 2013;13:1072.
    1. United Nations International Decades. 2017. (accessed May 29, 2017).
    1. Toe LC, Bouckaert KP, Beuf KD. Seasonality modifies the effect of a lipid-based nutrient supplement for pregnant rural women on birth length. J Nutr. 2015;145:634–639.
    1. Bhutta ZA, Das JK, Rizvi A. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013;382:452–477.
    1. Blencowe H, Cousens S, Chou D. Born too soon: The global epidemiology of 15 million preterm births. Reprod Health. 2013;10:S2.
    1. Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Semin Fetal Neonatal Med. 2012;17:12–19.
    1. Gyamfi-Bannerman C, Thom EA, Blackwell SC. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374:1311–1320.
    1. Reisman J, Arlington L, Jensen L, Louis H, Suarez-Rebling D, Nelson BD. newborn resuscitation training in resource-limited settings: a systematic literature review. Pediatrics. 2016;138:e20154490.
    1. Arlington L, Kairuki AK, Isangula KG. Implementation of ‘Helping Babies Breathe’: a 3-year experience in Tanzania. Pediatrics. 2017;139:e20162132.
    1. Network SSG of the EKSNNR Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362:1970–1979.
    1. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175–1188.
    1. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, Greenfield TK. Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention. Am J Epidemiol. 2008;168:866–871.
    1. Holmes MV, Dale CE, Zuccolo L. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.
    1. McCambridge J, Hartwell G. Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies. Drug Alcohol Rev. 2015;34:58–66.
    1. Bilano V, Gilmour S, Moffiet T. Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet. 2015;385:966–976.
    1. Fewtrell LJ, Prüss-Ustün A, Landrigan P, Ayuso-Mateos JL. Estimating the global burden of disease of mild mental retardation and cardiovascular diseases from environmental lead exposure. Environ Res. 2004;94:120–133.
    1. WHO . Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and non-partner sexual violence. World Health Organization; Geneva: 2013. (accessed Sept 1, 2017).
    1. WHO. UNICEF Joint Monitoring Programme for Water Supply and Sanitation. Jt. Monit. Programme. (accessed May 29, 2017).
    1. UNICEF. WHO. The World Bank . Joint child malnutrition estimates—Levels and trends. 2017 edition. World Health Organization; Geneva: 2017. (accessed May 29, 2017).
    1. WHO. UNICEF . Low birthweight: Country, regional, and global estimates. World Health Organization; Geneva: 2004. (accessed May 28, 2017).
    1. Hill NR, Fatoba ST, Oke JL. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.
    1. Blencowe H, Cousens S, Oestergaard MZ. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–2172.
    1. Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C, GAPPS Review Group Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth. 2010;10:S1.
    1. Lelieveld J, Evans JS, Fnais M, Giannadaki D, Pozzer A. The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature. 2015;525:367–371.
    1. Petry N, Olofin I, Hurrell RF. The proportion of anemia associated with iron deficiency in low, medium, and high human development index countries: a systematic analysis of national surveys. Nutrients. 2016;8:693.
    1. Takala J, Hämäläinen P, Saarela KL. Global estimates of the burden of injury and illness at work in 2012. J Occup Environ Hyg. 2014;11:326–337.
    1. Rushton L, Hutchings SJ, Fortunato L. Occupational cancer burden in Great Britain. Br J Cancer. 2012;107:S3–S7.
    1. Raffensperger C, Tickner JA. Protecting Public Health and the Environment: Implementing The Precautionary Principle. Island Press; Washington, DC, USA: 1999.
    1. Sandin P. Dimensions of the precautionary principle. Hum Ecol Risk Assess Int J. 1999;5:889–907.
    1. Foster KR, Vecchia P, Repacholi MH. Science and the precautionary principle. Science. 2000;288:979–981.
    1. Gasparrini A, Guo Y, Hashizume M. Mortality risk attributable to high and low ambient temperature: a multicountry observational study. Lancet. 2015;386:369–375.

Source: PubMed

3
Subscribe